ANI Pharmaceuticals | ANIP - Операционный доход





Операционный доход Изменить Дата
AbbVie USD 4.73B 1.08B 2026-03
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Canopy Growth CAD -27.47M 14.81M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Emergent BioSolutions USD -218M 69.9M 2023-06
Heron Therapeutics USD 38K 3.83M 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.24B 171M 2026-03
Omeros USD -35.41M 23.75M 2024-09
Perrigo USD 33.6M 50.8M 2026-03
Sun Pharmaceuticals INR 40.62B 6.95B 2025-12
Teva Pharmaceutical Industries USD 758M 271M 2026-03